|
ZymoGenetics Inc.Published by: SGA Lists Published: Oct. 1, 2009 - 2 Pages Table of Contents
AbstractZymoGenetics creates novel protein drugs with the potential to significantly help patients fight their diseases. The company is developing a diverse pipeline of potential proprietary product candidates that are moving into and through clinical development. These candidates span a wide array of clinical opportunities that include bleeding, autoimmune diseases and cancer. ZymoGenetics intends to commercialize these product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||